← Research library

Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten]

Observational study · 2010

What was studied
728 analyzable patients with psychoautonomic syndrome in 28 Russian centers
Main finding
Reports symptom and quality-of-life improvements during 28 days of Ladasten treatment and follow-up. The abstract reports adverse events in 3% and discontinuation in 0.8%.

CGI-S responders · 76.0%

Reported findings and study design

Uncontrolled multicenter report: 28 centers, 728 analyzed patients (91.6% of the enrolled sample). Ladasten 50–100 mg/day for 28 days; follow-up one month after treatment.

Population or model 728 analyzable patients with psychoautonomic syndrome in 28 Russian centers

Dose, route and schedule

Ladasten (bromantane): 50–100 mg/day for 28 days. The indexed abstract does not specify the route or how the daily dose was divided.

Protocol source ↗ · Indexed publication abstract

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
CGI-S responders76.0%
CGI-I responders90.8%
First reported antiasthenic effectDay 3
Adverse effects3%
Stopped therapy0.8%
Serious adverse effectsNone reported in this cohort

Responder percentages use different CGI scales. There is no concurrent placebo comparison in the abstract; the results are not independent of duplicate reports of this cohort.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • No concurrent comparator is described in the abstract; improvement alone does not establish causality.
  • PMID 21322821 has the same title, cohort and abstract: treat it as a related report of this cohort, not independent replication.
  • Short follow-up and incomplete ascertainment cannot rule out uncommon or long-term harms.

Source details

Indexed citation and abstract checked through Europe PMC / PubMed. Original methods and risk of bias not fully appraised.

Sources checked

Citation

Uncontrolled human reportEnglish abstract

Author unconfirmed. Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten] Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 110(5 Suppl 1):17-26. PMID 20559263

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards